Xingnaojing injection
2018YFC1705001
Approved small_molecule active
Quick answer
Xingnaojing injection for Acute Ischemic Stroke is a Approved program (small_molecule) at INTEGRATED BIOPHARMA INC with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INTEGRATED BIOPHARMA INC
- Indication
- Acute Ischemic Stroke
- Phase
- Approved
- Modality
- small_molecule
- Status
- active